Silvercrest Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.9M | Buy |
126,888
+12,130
| +11% | +$2.38M | 0.18% | 164 |
|
|
2026
Q1 | $22.5M | Buy |
114,758
+2,507
| +2% | +$487K | 0.16% | 170 |
|
|
2025
Q4 | $19.5M | Buy |
112,251
+2,910
| +3% | +$530K | 0.13% | 208 |
|
|
2025
Q3 | $20.8M | Buy |
109,341
+1,315
| +1% | +$233K | 0.14% | 199 |
|
|
2025
Q2 | $19.4M | Sell |
108,026
-44
| -0% | -$7.64K | 0.13% | 208 |
|
|
2025
Q1 | $18.3M | Buy |
108,070
+27,349
| +34% | +$4.49M | 0.13% | 199 |
|
|
2024
Q4 | $12.2M | Buy |
80,721
+79,099
| +4,877% | +$12.3M | 0.08% | 260 |
|
|
2024
Q3 | $252K | Hold |
1,622
| – | – | ﹤0.01% | 746 |
|
|
2024
Q2 | $222K | Sell |
1,622
-100
| -6% | -$13.7K | ﹤0.01% | 858 |
|
|
2024
Q1 | $229K | Sell |
1,722
-4
| -0.2% | -$519 | ﹤0.01% | 835 |
|
|
2023
Q4 | $238K | Hold |
1,726
| – | – | ﹤0.01% | 775 |
|
|
2023
Q3 | $210K | Hold |
1,726
| – | – | ﹤0.01% | 791 |
|
|
2023
Q2 | $243K | Sell |
1,726
-70
| -4% | -$9.65K | ﹤0.01% | 777 |
|
|
2023
Q1 | $254K | Hold |
1,796
| – | – | ﹤0.01% | 739 |
|
|
2022
Q4 | $281K | Hold |
1,796
| – | – | ﹤0.01% | 722 |
|
|
2022
Q3 | $220K | Hold |
1,796
| – | – | ﹤0.01% | 745 |
|
|
2022
Q2 | $239K | Hold |
1,796
| – | – | ﹤0.01% | 751 |
|
|
2022
Q1 | $246K | Sell |
1,796
-11
| -0.6% | -$1.53K | ﹤0.01% | 792 |
|
|
2021
Q4 | $313K | Buy |
1,807
+211
| +13% | +$32.1K | ﹤0.01% | 733 |
|
|
2021
Q3 | $232K | Hold |
1,596
| – | – | ﹤0.01% | 792 |
|
|
2021
Q2 | $211K | Hold |
1,596
| – | – | ﹤0.01% | 801 |
|
|
2021
Q1 | $205K | Buy |
+1,596
| New | +$197K | ﹤0.01% | 804 |
|
|
2018
Q3 | – | Sell |
-1,848
| Closed | -$203K | – | 544 |
|
|
2018
Q2 | $203K | Sell |
1,848
-150
| -8% | -$15.6K | ﹤0.01% | 531 |
|
|
2018
Q1 | $200K | Buy |
+1,998
| New | +$205K | ﹤0.01% | 536 |
|
|
2017
Q4 | – | Sell |
-2,298
| Closed | -$215K | – | 576 |
|
|
2017
Q3 | $215K | Hold |
2,298
| – | – | ﹤0.01% | 522 |
|
|
2017
Q2 | $255K | Hold |
2,298
| – | – | ﹤0.01% | 487 |
|
|
2017
Q1 | $226K | Sell |
2,298
-124
| -5% | -$11.8K | ﹤0.01% | 533 |
|
|
2016
Q4 | $223K | Buy |
+2,422
| New | +$209K | ﹤0.01% | 537 |
|
|
2016
Q1 | – | Sell |
-3,500
| Closed | -$249K | – | 545 |
|
|
2015
Q4 | $249K | Buy |
+3,500
| New | +$235K | ﹤0.01% | 511 |
|
Other funds holding DGX
EIG
Silvercrest Asset Management's DGX Position: Q2 2026 in Review
Silvercrest Asset Management increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $2.38M and bringing the position to 126,888 shares worth $26.9M. The position accounts for 0.18% of the portfolio, ranked #164.
Silvercrest Asset Management first reported a position in DGX in Q4 2015 and has held it in 29 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Silvercrest Asset Management held 126,888 shares of Quest Diagnostics worth $26.9M as of Q2 2026.
- Silvercrest Asset Management bought 12,130 Quest Diagnostics shares in Q2 2026, an estimated $2.38M.
- Quest Diagnostics made up 0.18% of Silvercrest Asset Management's portfolio in Q2 2026, its #164 holding.
- Silvercrest Asset Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 29 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.